Two promising projects have been selected to undergo preclinical testing as part of the Cystic Fibrosis Technology Initiative (CFTI). The CFTI provides a bold step towards meeting the needs of the Canadian cystic fibrosis (CF) research community in the area of drug development through a unique collaboration between Cystic Fibrosis Canada, the University of British Columbia (UBC), and The Centre for Drug Research and Development (CDRD). More ....
Reviewed/updated: 2011-07-13